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ABSTRACT Clots of human ,8-fibrin, in which only (or predominantly) the B fibrinopeptide is released, were formed at
140C by copperhead venom procoagulant enzyme (CVE or venzyme), at pH 8.5, ionic strength 0.45. The shear modulus
of elasticity increased slowly and after several days attained a constant value, which was lower than those of a-fibrin or
a,3-fibrin under the same conditions. Before studying the temperature dependence of elasticity, the CVE was then
inhibited by introducing phenyl methyl sulfonyl chloride (PMSF) by diffusion. With increasing temperature, the
modulus decreased progressively from 50C to nearly zero at 350 and was essentially reversible with temperature change;
recovery of elasticity after change from 34.50 to 140 required -2 d but was considerably faster than the initial buildup of
elasticity by CVE at 140. Creep and creep recovery measurements on unligated clots showed creep rates and
irrecoverable deformation that were similar in magnitude to those of a-fibrin clots formed with batroxobin and much
larger than those of a(3-fibrin clots formed with thrombin, under the same conditions. During creep and creep recovery,
the differential modulus or compliance remained constant, showing that there was no permanent structural damage,
and if network strands are severed in slow flow, they must rejoin in new configurations. Introduction (by diffusion) of
the tetrapeptides Gly-His-Arg-Pro (GHRP) and Gly-Pro-Arg-Pro (GPRP), which resemble the B and A binding sites
on the E domain of fibrin respectively, reduced the shear modulus and increased the creep rate of (3-fibrin clots to an
extent similar to the effect ofGPRP on afB-fibrin, much more than that of GHRP on a,#-fibrin, but much less than that
of GPRP on a-fibrin. A ligated ,-fibrin clot formed with Factor XIIIa (in which the activating thrombin had been
neutralized by hirudin) showed essentially perfect elastic behavior, with no creep and with complete recovery after
removal of stress, and was inert to GHRP.
INTRODUCTION
Thrombin converts fibrinogen to fibrin monomer by cleav-
ing two moles each of the fibrinopeptides A and B (1),
uncovering noncovalent binding sites which can interact
respectively with sites designated (2) "a" and "b" on other
fibrin monomer molecules. The Aa junctions are sufficient
for self-assembly of fibrin monomers in the staggered
overlapping pattern to form the protofibril, which is the
first stage in the construction of a fibrin clot. The B
fibrinopeptides are released more slowly than the A. The
Bb junctions which are then established have been thought
to be involved in the lateral aggregation of protofibrils
(3, 4), although such aggregation can take place without
them. However, it is evident from recent work that the Bb
junctions also stabilize the binding of fibrin monomers
together within the protofibrils themselves (5-6a).
The roles of the Aa and Bb junctions can be investigated
by studying the action on fibrinogen of certain snake
venom enzymes that remove the A or B fibrinopeptides
selectively (7). Ancrod (from Agkistrodon rhodostoma)
and batroxobin (from Bothrops atrox or Bothrops mooje-
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ni) cleave A only; CVE or venzyme (from Agkistrodon
contortrix contortrix) cleaves B only, or at least highly
preferentially, under certain conditions (8). Fibrin mon-
omer lacking both fibrinopeptides is often designated as
(a#'Y)2 or a#-fibrin; lacking A, as (aBf3Y)2 or a-fibrin;
lacking B, as (Aca3'y)2 or f-fibrin.
a-Fibrin monomer polymerizes to form oligomers and
clots that resemble those from a#-fibrin (6) except that the
clots have very different mechanical properties (6a, 9).
Also, ,8-fibrin polymerizes to form oligomers and clots but
only at lower temperatures; both dissociate into smaller
oligomers at temperatures approaching 370C and into
monomers when diluted to 0.2 mg/mL at 370C (10, 11).
Electron microscopy of the three types of clots shows
striking similarities (6, 12) and it is evident that all three
types of protofibrils are based on the staggered overlapping
pattern in which A and B sites on the central fibrin nodule
interact respectively with "a" and "b" sites on the terminal
nodules of two other fibrin monomers.
The association and gelation of ,B-fibrin, their reversibil-
ity with temperature change, and ligation (cross-linking)
by Factor XIIIa have been studied in several investigations
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by Shainoff, Furlan, Mosesson, and others (5, 8, 10-14).
However, there have been no quantitative measurements of
mechanical properties of f-fibrin clots. The present paper
reports measurements of the shear modulus of elasticity
and its dependence on temperature, viscoelastic creep, and
creep recovery, and the effects on mechanical properties of
the introduction, by diffusion into a clot, of the tetrapeptide
Gly-His-Arg-Pro (GHRP) which resembles the N-termi-
nal sequence of the B site and binds to the "b" site (15, 16),
as well as Gly-Pro-Arg-Pro (GPRP), which resembles the
"a" site and binds to it but also binds to the "b" site (16).
Previous studies (6a, 9, 17-20) of the viscoelastic prop-
erties of af-fibrin and a-fibrin clots may be briefly sum-
marized as follows. These statements refer to "fine" clots
formed at pH 8.5, ionic strength 0.45, where there is
minimal lateral aggregation of protofibrils ("fine clot"
conditions), and to small shear deformations. Unligated
af3-fibrin clots subjected to constant stress show an initial
elastic deformation ("initial" in our experiments means 25
s after imposition of stress) followed by creep (gradual
increasing deformation). After removal of stress, the creep
recovery is incomplete and the irrecoverable deformation is
proportional to the stress duration. Introduction of the
tetrapeptide GPRP, which binds to the "a" site and
inhibits (15) polymerization of acq-fibrin monomers,
diminishes the shear modulus (ratio of stress to strain at 25
s), and increases enormously the creep rate and irrecovera-
ble deformation. The creep deformation becomes a linear
function of time so the clot containing GPRP appears to
flow like a highly viscous viscoelastic liquid. By contrast,
clots ligated by Factor XIIIa show no creep, only an initial
elastic deformation which is completely recovered after
removal of stress, and are unaffected by the introduction of
GPRP.
Unligated a-fibrin clots have somewhat lower shear
moduli and larger creep rates and irrecoverable deforma-
tions than af3-fibrin clots. They are also far more suscepti-
ble to the action of GPRP in lowering the shear modulus
and further increasing creep rates and irrecoverable defor-
mations. These observations, as well as studies of the
interaction of GPRP with oligomers (6a, 20) support the
view (5, 6) that Bb contacts stabilize the bonding of
individual a3-fibrin monomers within protofibrils. It is of
particular interest, therefore, to study clots in which there
are only Bb contacts, and their interaction with GHRP
which binds to the "b" sites, as well as GPRP which also
binds to the "b" sites.
MATERIALS AND METHODS
Lyophilized human fibrinogen, Imco Lot F176, was generously given us
by Drs. B. Blomback and R. Procyk, New York Blood Center. It was
dissolved in Tris-HCI/NaCl buffer, pH 8.5, ionic strength 0.45, of which
0.40 was contributed by NaCl. After dialysis against this buffer at 40C
for 2 d with several changes, aliquots were frozen with liquid nitrogen and
stored at -10°C. After each was thawed, fibrinogen concentration was
measured spectrophotometrically at 282 nm, with correction for scatter-
ing by subtraction of absorbance at 320 nm.
Bovine thrombin was obtained from Parke-Davis and Co., Detroit, MI.
CVE enzyme from A. contortrix cortortrix, purified by chromatofocus-
ing, was generously provided by Dr. John R. Shainoff, Cleveland Clinic
Foundation. Trasylol (plasmin inhibitor) was obtained from FBA phar-
maceuticals, New York; phenyl methyl sulfonyl fluoride (PMSF) and
hirudin from Sigma Chemical Co., St. Louis, MO; and tosyllysine
chloromethyl ketone (TLCK) from Aldrich Chemical Co., Milwaukee,
WI. Materials for gel electrophoresis (acrylamide and cross-linking
comonomer, ammonium persulfate, and Coomassie Brilliant Blue dye)
were obtained from Biorad Laboratories, Richmond, CA. Factor XIII
(fibrin stabilizing factor) was generously furnished by Professor L.
Lorand, Northwestern University.
Because the fibrin clots were kept for long periods (up to two weeks)
during mechanical measurements, inhibitors were added to the fibrinogen
solutions, before clotting, to inactivate possible though unlikely traces of
foreign enzymes: Trasylol (2 U/mL) for plasmin, hirudin (5 U/mL) for
thrombin, and TLCK (0.1 mM) for a fibrinolytic enzyme originally
present in the snake venom (10, 12). Unless ligation was desired, the
solutions contained 1.5 mM EDTA. When a ligated clot was required, the
EDTA was replaced by 3.2 mM calcium chloride plus Factor XIIIa as
noted. The latter was prepared by activating Factor XIII (at 150 mg/L)
with thrombin (0.6 U/mL) and calcium chloride (0.016 M) for 90 min.
and then inactivating the thrombin by hirudin (45 U/mL). The proce-
dures for disc gel electrophoresis have been previously described (20-
22).
The apparatus for measurements of elastic modulus and creep has been
previously described (18, 20, 23). The solution to be clotted, containing
approximately 8.5 mg/mL fibrinogen, was cooled to 140C, CVE was
added, and it was introduced between the parallel circular plates of the
apparatus, which had been precooled to 140C, to avoid release of A
fibrinopeptides at higher temperatures (8-10). Separate aliquots were
monitored for clotting time and kept for gel electrophoresis measure-
ments. After clotting, the shear modulus G2s was measured intermittently
by imposing a torque e for 25 s, measuring the angular displacement a,
and returning the torque immediately to zero. Here, G25 is calculated by
the relation, (23)
G25 = 2eVh/lra4a (1)
where h is the distance between the plates (about 0.12 cm) and a is the
plate radius (2.5 cm). The shear strains in the disc-shaped clot were
always very small (maximum, at the disc periphery, about 1% at the
beginning of a creep experiment and 6% at the end). After G25 had
increased to a constant value, requiring several days, a creep experiment
was done at constant torque; the angular displacement a(t) was followed
as a function of time. The creep compliance J(t) is
J(t) = va'a(t)12eh (2)
The initial value, J1, is simply the reciprocal of G25. The final value at time
t, is denoted by J'. At tl, a differential compliance J, was determined
from an incremental angular displacement 25 s after application of an
incremental torque (about half the original torque). Then the torque was
removed, and creep recovery began. After 25 s the compliance had
decreased to J,. It gradually decreased further to a final value J,, a
measure of permanent deformation. Finally, after creep recovery, an
incremental torque was applied again and the resultant angular displace-
ment was measured to obtain the differential compliance J. final. These
various compliances monitor possible changes in clot structure (9, 19).
When measurements were to be made at different temperatures, the
CVE in the clot was inactivated at 140C by diffusing in from the clot
periphery PMSF over a period of 40 h to a nominal concentration of 0.5
mM to prevent release ofA fibrinopeptide at higher temperatures (8, 10).
The arrangement for this diffusion procedure has been described previ-
ously (19, 20).
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RESULTS
Dependence of Shear Modulus on
Time and Temperature
The buildup of shear modulus with time at 140C after
clotting of a solution containing 0.38 TAME units (8) of
CVE per mL is shown in Fig. 1. For comparison with clots
of af3 and a-fibrin under the same conditions, formed with
thrombin and batroxobin respectively (6a), G25(t)/G25 is
plotted against t/tc, where Gf25 is the final modulus value
and t, is the clotting time. Values of tc, Gf25, and fibrinogen
concentration [F] are given in the legend.
The clotting time for f-fibrin under "fine clot" condi-
tions is much longer than at pH 7.3, ionic strength 0.15
(8, 10). The buildup of rigidity relative to the clotting time
is also strikingly slow compared with the behavior of
a-fibrin and afl-fibrin; half the final elastic modulus is
attained at t = 7tc, compared with -2tc for the others. The
inset shows results of gel electrophoresis under reducing
conditions on aliquots quenched by SDS at times indicated
by a to e on the graph for fA fibrin and compared with a
fully developed thrombin clot (Th) and fibrinogen (0).
The displacement of the chain indicates that the release
of the B peptide is complete at b, -6 times tc. Thus the
release of B is not the rate-determining step in the slow
buildup. (Release ofA peptide is the rate-determining step
in polymerization of a/3-fibrin under similar conditions
(24).) At later times, the a chain appears to have under-
gone some attack in spite of the enzyme inhibitors present.
Similar behavior was observed by Mosesson and collabora-
tors (13).
For a similar experiment with CVE, the modulus G25 is
plotted directly against real time in Fig. 2. The course of
buildup agrees quite well with that in Fig. 1, although the
final modulus is somewhat higher (670 dyn/cm2). Creep
t c
t/tc
FIGURE 1 Shear modulus relative to its final value plotted against t/t1.
,, CVE 0.38 U/mL, [F] - 8.54 mg/mL, t,, 9 h, G'5 490 dyn/cm2
(exp. 93); a, batroxobin 0.1 U/mL, [F] = 8.51 mg/mL, tc, = 90 min,
Gfs = 1,300 dyn/cm2 (Exp. 84); a,B, thrombin 0.19 U/mL, [F] = 8.57
mg/mL, tr = 32 min, Gf5 - 1,860 dyn/cm2 (Exp. 90). Inset: reduced gel
electrophoresis on aliquots of #-fibrin taken at times indicated by a to e on
graph; Th is for fully developed thrombin clot, 0 is fibrinogen.
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FIGURE 2 Shear modulus plotted directly against time for clot of
fibrin, [F] = 8.60 mg/mL, CVE 0.38 U/mL, t, 8.5 h (exp. 87). Times
of creep experiment and of introduction of PMSF are shown. Black
circles: buildup of G25 after temperature change from 34.50 to 1 4.0°C (cf.,
Fig. 3). The abscissa unit (105 s) is -1 d.
and creep recovery measurements were made at 14.20 after
-5 d, and on the sixth day PMSF was diffused in to
inactivate the enzyme. Then measurements were made at a
series of different temperatures in the order 14.20, 5.00,
12.20, 25.00, 30.00, 14.20, 34.5°, and 14.00. After each
temperature change, G25 was followed as a function of time
and reached a plateau level within 3 to 5 h except when the
temperature was lowered from 300 or higher. During this
sequence of temperature changes, the age of the clot
increased from 7 to 12 d. Unfortunately, the temperature
itself is slow to come to equilibrium in this apparatus and
no conclusions can be drawn about the kinetics of changes
in the fibrin network for times shorter than -2 h. However,
the buildup of G25 after the final change from 34.50 to
14.00 required at least 2 d and is plotted with black circles
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FIGURE 3 Shear modulus plotted against temperature for clot of ,B-
fibrin, Exp. 87 (cf. legend of Fig. 2). Numerals denote sequence of
measurements. Solid circles: similar measurements for a clot of a#3 fibrin,
[F] - 8.57 mg/mL, thrombin 4.2 U/mL, t,, = 27 min. (Exp. 83). Dashed
line is average of measurements 7 to 12 inciusive. Note the difference in
ordinate scale.
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in Fig. 2. The fact that G25, starting from 15 dyn/cm2 at
34.50, attains a value at 14.00 (530) nearly as high as the
initial value when the clot was first formed at 14.20 (670)
gives some reassurance that there has been no deleterious
effect of degradation of the protein despite the extreme
duration of the experiment. The buildup of rigidity after
lowering the temperature, although slow, is much faster
than that following the original clotting, despite the conclu-
sion that in the latter the release of B peptide is not the
rate-determining step. A similar conclusion was reached by
Mosesson and collaborators (12) by following opacity
measurements.
The plateau values of G25 are plotted against tempera-
ture in Fig. 3, with numerals denoting the sequence of
measurements. The points below 140 are somewhat erratic
but the sharp drop in the range 200-300 agrees with earlier
qualitative observations (8, 10) at lower pH and ionic
strength. The sequence 5-6-7-8 shows rather good reversi-
bility between temperatures where the clot is nearly lique-
fied and where the modulus is near its maximum value.
The fact that, after the CVE had acted for 6d, the clot
could be essentially liquefied at 300 is evidence that the
results are not affected by any slow release of fibrinopep-
tide A. (In a qualitative test, a CVE clot was liquefied at
370 and the solution was divided into two aliquots; to one,
batroxobin was added to a concentration of 1.25 U/mL;
both were incubated at ambient temperature, at which
they gelled, for 2 d. Upon warming to 370, the gel with
batroxobin, which releases the A peptides, remained solid,
and the other liquefied.) Facilities were not available to
determine the A release directly.
Fig. 3 includes, for comparison, data for the temperature
dependence of G for a clot of unligated afl-fibrin formed
with thrombin at the same pH, ionic strength, and fibrino-
gen concentration (but a much shorter clotting time, 27
min). The temperature range here was from 5.2 to 30.30C.
The measurements in sequence 1-6 were made within a
period of clot age from 43 to 76 h; those in sequence 7-12
within a period from 115 to 142 h. The scatter within each
group appears to be random, and the average for the
second group is drawn as a horizontal dashed line. From
these measurements, there seems to be no significant
dependence of modulus on temperature in a thrombin clot.
(In a very early study (25) of bovine fibrin of lower purity
at pH 7 by an entirely different experimental method, a
moderate reversible decrease in G with increasing temper-
ature was reported. We have no explanation for this
difference.)
Interaction with GHRP and GPRP: Shear
Modulus and Creep
To determine the effect of GHRP on clot mechanical
properties, the tetrapeptide was diffused in from an
approximately equal volume of external solution with twice
the desired tetrapeptide concentration in the same buffer,
as previously described (18, 19), at 140C. The decrease in
G25 was followed with time as in earlier experiments where
GPRP was introduced into clots of a-fibrin and afl-fibrin
(6a, 19, 20). The concentration is expected to be nearly
equalized after 1 d (20), though a small further drop in G25
is observed after 2 d. In the first diffusion, the nominal
GHRP concentration was 0.5 mM (assuming complete
equalization); in the second, after replacing the external
solution with a more concentrated charge, it was 2.3 mM
(Exp. 93). A similar sequence was performed with the
other tetrapeptide, GPRP, in which the nominal concen-
tration after the first diffusion was 0.1 mM and after the
second 1.0 mM (Exp. 102). The ratio G25/G25(0), where
G25(0) is the modulus before introduction of GHRP, after 1
and 2 d is given with other information in Table I.
In Fig. 4, G25/G25(0) (after 2 d) is plotted against
TABLE I
SHEAR MODULI AND CREEP COMPLIANCES (UNITS DYN/CM2 AND CM2/DYN RESPECTIVELY), AT 140C
GIG(O) GIG(O) jl X 14 tl, ja X 04 J,- J. J,&(final)Expt. Fibrin [F] Peptide [P] G25(0) G/G(0) G/G(0) d x 104 Xio4 14x 10 x i04
mg/mL mM
87 ,B 8.6 - 670 16.4 1.2 16.2 15.7 16.1
93 f8 8.5 490 - 21.3 1.2 21.6 20.6 20.7
GHRP 0.5 0.60 0.51 40 1.2 40 40 40.4
GHRP 2.3 0.21 0.16 126 0.3 117 117 126
102 13 8.5 - 460 - 22.7 1.3 21.5 22.6 22.3
GPRP 0.1 0.91 0.86 25.2 1.3 25.5 24.8 25.6
GPRP 1.0 0.20 0.12 188 0.4 187
98 , 8.5 1420 7.1 1.2 6.9 7.0 7.0
GHRP 6.0 0.99 0.97 7.25 1.2 7.0 7.3 7.3
84t a 8.5 1300 - 7.8 1.2 7.3 7.1 7.9
904: a/3 8.6 1890 5.2 9.5 5.1 5.4 5.4
96t a,3 8.5 1860 5.4 1.2 5.1 5.5 5.4
*Ligated by Factor XIIIa and calcium.
tMeasurements at 22 ± 1°C.
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FIGURE 4 Shear modulus ratio after diffusion for 2 d plotted against
nominal concentration of tetrapeptide: GHRP and GPRP (crossed
circles) for ,B-fibrin, GPRP for a-fibrin and ac,-fibrin (7). Point with pip
up is for fibrin concentration 15.0 mg/mL.
tetrapeptide concentration for both tetrapeptides and com-
pared with similar data for introduction of GPRP into
a-fibrin and af-fibrin clots prepared from Imco fibrino-
gen. It is evident that /-fibrin is much less susceptible to
dissociation by GHRP than a-fibrin is to GPRP. The
effect of GHRP on the modulus of A-fibrin is quite similar
in magnitude to that of GPRP on af3-fibrin. However,
GPRP lowers the modulus of A-fibrin even more than
GHRP does. (A single experiment from Reference 19, not
shown, gave the effect ofGHRP on ad-fibrin as G/G [0] =
0.79 at 5.6 mM, trivial in comparison with the others; and
another showed a synergistic effect of GPRP and GHRP
combined.)
Creep and creep recovery data for a Al-fibrin clot before
introduction of GHRP and at two levels ofGHRP concen-
tration are shown in Fig. 5. Numerical data for JI, t,, J,
J'- J,, and J, (final) are included in Table I, for these as
well as two other clots without GHRP, in reasonable
agreement, and clots containing GPRP at two different
levels, also representative data for a-fibrin and a/3-fibrin
clots from Imco fibrinogen from previous measurements
(6a).
t,
time, szI0-
FIGURE 5 Creep and creep recovery of ,B-fibrin clot before (0) and after
introduction ofGHRP to nominal concentrations of 0.5 and 2.3 mM (exp.
93). Additional data in Table I.
It is evident from Fig. 5 that GHRP increases both the
creep rate and the irrecoverable deformation of A-fibrin,
just as GPRP does for a-fibrin and af3-fibrin (6a, 20).
Similar increases were observed for A-fibrin clots contain-
ing GPRP, but the latter was somewhat more effective as
will be seen from comparison of viscosities. Even without
GPRP, the creep and creep recovery of d3 fibrin, like those
of a-fibrin, resemble the behavior of a viscoelastic liquid,
and the reciprocal slope of the linear portion of the creep
curve represents a steady-flow viscosity. A detailed com-
parison of the properties of the three types of fibrin will
follow. In Table I, the columns J,A, J' - J., and J, (final)
are of particular interest. These represent a differential
compliance measured 25 s after a step change in stress (the
removal of the original torque at time t1 is equivalent to a
negative stress change and J' - J. is the corresponding
change in compliance). All these quantities are essentially
equal and in agreement with the initial compliance J,. This
shows, as has been found to be the case for afi- and
a-fibrins both with and without GPRP, that even though
substantial flow occurs the network structure has not been
damaged, and if network strands have been severed they
must form again in new configurations.
In Table II, values of viscosity 7 and steady-state
compliance J' (a measure of recoverable elastic deforma-
tion, given by the intercept of the linear segment of the
creep curve on the ordinate axis) are listed, as well as the
logarithm of the product 7J°, which represents a weight-
average viscoelastic relaxation time (20). Comparison with
a- and af3-fibrins in Tables I and II shows that both a and 3
types have somewhat lower moduli and enormously lower
viscosities (orders of magnitude) than the normal fibrin
formed with thrombin. The moduli and viscosities of a- and
#-fibrin are of similar magnitudes, though a-fibrin has a
somewhat higher modulus and somewhat lower viscosity.
The average relaxation time is somewhat higher for ,B-
fibrin.
The viscosity is plotted logarithmically against concen-
TABLE II
EFFECTIVE VISCOSITIES AND STEADY STATE
COMPLIANCES, AT 140C
Expt. Fibrin Peptide [P] q x 10-7 J° x 104 log Jo
P cm2/dyne units s
87 ,- 0.37 24 3.95
93 ,B - 0.25 33 3.91
GHRP 0.5 0.09 69 3.79
GHRP 2.3 0.012 216 3.41
102 /3 0.24 35 3.92
GPRP 0.1 0.17 45 3.89
GPRP 1.0 0.015 325 3.68
84* a 0.19 25 3.68
90* a,3 (39)t 7.4* 5.46*
*Measurements at 22 ± 1°C.
tA lower limit because it is doubtful whether steady state flow is
achieved.
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tration for both tetrapeptides in Fig. 6, with comparisons
(6a, 20) for a-fibrin and afl-fibrin with GPRP. Although
the reduction of viscosity of A-fibrin by GHRP is substan-
tial, it is relatively less than the effect of GPRP on
af-fibrin and far less than the spectacular reduction by
GPRP in a-fibrin. The viscosity of A-fibrin, like the
modulus, is lowered more by GPRP than by GHRP at a
comparable concentration. It may be noted that all the
viscosities are exceedingly high compared with those of
ordinary liquids; for example, that of glycerol is 9 poise at
25.0°C. The product ofqJ° in Table II will be considered in
the Discussion section.
Ligated :-Fibrin Clots
The action of CVE on fibrinogen in the presence of Factor
XIIIa and calcium produces a clot with y--y ligation (11).
The increase in shear modulus with the progress of time in
such a clot is plotted in Fig. 7. The modulus builds up more
rapidly than for the corresponding unligated clot, repro-
duced for comparison from Fig. 2, and reaches a considera-
bly higher limiting value. After 5 d, the y-'y ligation was
essentially complete. No a - a dimers or polymers were
observed, although the a-chains were degraded as in the
unligated clots.
Creep and creep recovery data for this clot before and
after introduction of GHRP to a very high nominal
concentration of 6 mM are shown in Fig. 8, and numerical
data are included in Table I. The contrast with the
unligated clots (Fig. 5) is striking. There is essentially no
creep, just an immediate elastic deformation, and the
recovery after removal of stress is almost instantaneous
and complete; the behavior is almost that of a perfect
elastic solid. Thus introduction of GHRP at a much higher
concentration than that which decreases the modulus (Fig.
4) and greatly increases creep rate and irrecoverable
deformation (Fig. 5) of unligated clots has practically no
effect on the modulus. In the presence of the GHRP, there
35], BPei ~,a,;OHP
6t. I,j.,.0
Nominal Tetrapiptide COcentration, mM
FIGURE 6 Logarithm of viscosity from slope of linear portion of creep
curve plotted against nominal concentration of tetrapeptide: GHRP and
GPRP (crossed circles) for #-fibrin, GPRP for a-fibrin and ca#-fibrin.
Fibrin concentrations -8.5 mg/mL except for points with pips, 15.0
mg/mL.
FIGURE 7 Shear modulus plotted against time for ligated clot of
,8-fibrin, Exp. 98, [F] = 8.45 mg/mL, CVE 0.38 U/mL, Factor XIIIa 4.8
mg/L, t, = 6 h. Dashed curve is for unligated clot, reproduced from Fig.
2. The abscissa unit is -1 d.
is still almost no creep or flow and nearly perfect elastic
recovery. As expected, the various J values in Table I agree
since the structure is stable and not rearranging as it does
in unligated clots. Similar behavior has been found for
ligated fine clots of af-fibrin and a-fibrin (6a), which are
unaffected by the introduction of GPRP by diffusion.
DISCUSSION
As pointed out in previous communications (6a, 20), the
modulus G25 is a measure of the ability of the fibrin
structure to store elastic energy, while the creep rate and
viscosity are measures of the rate (and its reciprocal,
respectively) of rearrangements of the structure.
The reversible temperature dependence of G indicates
that the structure of unligated 3-fibrin is subject to disso-
ciation in an accessible temperature range, and experi-
ments with oligomers (5, 12) indicate that the dissociation
is between monomer units within the protofibrils and
involves the Bb associations. Two monomers in staggered
overlapping configuration are joined by two Bb junctions.
0
-Z9
C-
c
._
u
CL
8 _
6-
4-
2-
00 0.5 1.0 T 1.5 2.0
ti
Time, S Xl1Y4
FIGURE 8 Creep and creep recovery of ligated #3-fibrin clot before and
after introduction of GHRP to a nominal concentration of 6.0 mM (exp.
98). Additional data in Table I.
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Various experiments with oligomers of af-fibrin
(20, 26, 27) or a-fibrin (28) have been interpreted in terms
of an equilibrium constant for dissociation of two mono-
mers in which pairs of both Aa and Bb junctions, or pairs of
Aa junctions alone, maintain the contact. However, the
dissociation equilibrium lies so far on the left (unless
disruptive reagents such as GPRP (20) or hexanediol (27)
are present) that its dependence on temperature probably
cannot be detected. With Bbjunctions alone, the binding of
two monomers together is evidently much weaker.
Unfortunately the lack of a theory relating the magni-
tude of G to the degree of dissociation of the A-fibrin
structure prevents the use of Fig. 3 to calculate an equilib-
rium constant and an enthalpy of dissociation. However, it
may be noted that a small increase, with increasing
temperature, of the proportion of dissociated Bb junction
pairs can cause a large change in G, because a single break
in a clot network strand can remove the contribution of the
entire strand to the elastic modulus (20). Thus G may fall
to a very low value at 34.50 when only a modest fraction of
Bb junctions are dissociated. This probably explains why
the rate of G buildup in Fig. 2 is so much faster after a
temperature change from 34.5 to 140 than in the original
polymerization at 140; extensive oligomeric complexes are
undoubtedly already present in the former case.
The product qJ represents a weight-average viscoelas-
tic relaxation time related to whatever structural rear-
rangements are occurring (6a, 20). If the flow process
under constant stress is attributed to severance of network
strands, q7J° can be identified with the average lifetime of
an intact strand (20), i.e., the average time between breaks
in a single strand, - 1.3 h for a-fibrin and 2.4 h for d-fibrin.
One may speculate about the relation of this to the lifetime
of an association between two monomer units and hence
the rate of dissociation in the formulation of a dissociation
equilibrium. If the rate constants for dissociation are
similar in magnitude for these two fibrins, and the equilib-
rium constant for dissociation is much larger for j-fibrin, it
follows qualitatively that the rate constant for association
is lower for A-fibrin, in qualitative agreement with the
comparisons in Fig. 1. Of course, a/3-fibrin has a much
longer strand lifetime in this interpretation as well as
presumably a much smaller dissociation equilibrium con-
stant. This speculation ignores many aspects, including the
number of dissociable monomer contacts in a network
strand and the number of protofibrils in a strand bundle.
However, one feature is unambiguous, namely, if there is a
steady state of dissociation and reassociation of strands in
new configurations during flow under constant stress, the
actual rates of dissociation and reassociation must be the
same because of the equality of J1, J" J' -J., and J, final
in Table I.
We now turn to the effects of the tetrapeptides GHRP
and GPRP. Binding experiments by Laudano and Doolittle
(18, 29) with radioactive peptides, including use of ,B-fibrin
from the action of thrombin on lamprey fibrinogen, show
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FIGURE 9 Logarithm of weight-average relaxation time plotted against
nominal concentration of tetrapeptide. Points half filled, #-fibrin with
GHRP; crossed, ,B-fibrin with GPRP; dashed curve, a-fibrin with GPRP
(from Reference 7).
that GPRP is bound noncovalently to the "a" sites and less
strongly to the "b" sites; GHRP is bound only to the "b"
sites and somewhat less strongly to these sites than GPRP.
We postulate as before (6a) that the associations between
fibrin monomers are stabilized by both Aa and Bb junc-
tions and that tetrapeptides compete with the A and B sites
in accordance with these relative binding strengths.
In a-fibrin, the strong binding of GPRP to the "a" sites
displaces A sites and there are no Bb junctions, so G and q
are sharply decreased at very low GPRP concentrations. In
af#-fibrin, higher GPRP concentrations are needed for the
same effect because the Bb junctions must also be disso-
ciated and the binding of GPRP to the "b" sites is weaker.
In ,8-fibrin, the Bb junctions are dissociated by either
tetrapeptide, but somewhat more effectively by GPRP
because it binds more strongly than GHRP to the "b" sites.
In af3-fibrin, GHRP has only a small effect (19, 20) and a
combination of the two tetrapeptides is more effective than
either (19). Thus, qualitatively, all the observed results can
be explained in terms of equilibrium displacements.
When the effects of the tetrapeptides on qJ° are exam-
ined, the difference between a-fibrin and ,B-fibrin is
emphasized, as seen in Fig. 9. With the interpretation of
this product as the average lifetime of a network strand, it
appears that GPRP greatly increases the rate of dissocia-
tion of monomer contacts within a-fibrin protofibrils but
both tetrapeptides, in the same concentration range, affect
the rate of dissociation in ,B-fibrin only slightly. Their
action on ,8-fibrin is principally to decrease the equilibrium
number of strands contributing to the elasticity, rather
than the kinetics of their rearrangement.
Finally, the essentially perfect elastic behavior of ligated
clots both with and without GHRP shows that -y-y
ligation (even without a- a ligation) completely eliminates
the structural rearrangements that are responsible for
creep and flow in unligated clots, and reinforces the
hypothesis that the latter are due to severance of network
strands.
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